Effect of temporal pulse shape on urinary stone phantom retropulsion rate and ablation efficiency using holmium:YAG and super-pulse thulium fibre lasers.


Journal

BJU international
ISSN: 1464-410X
Titre abrégé: BJU Int
Pays: England
ID NLM: 100886721

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 12 4 2020
medline: 1 12 2020
entrez: 12 4 2020
Statut: ppublish

Résumé

To investigate the effects of laser temporal pulse shaping of the super-pulse thulium fibre laser (SPTFL) and to compare these in controlled in vitro conditions with various holmium: yttrium aluminium garnet (Ho:YAG) pulse delivery modes. The SPTFL (Urolase SP, IRE-Polus, Fryazino, Russia), with an emission wavelength of 1.94 μm, and a Ho:YAG laser (P120H; Lumenis, Yokneam, Israel) with Moses technology were compared. Pulse shape, stone retropulsion and ablation efficiency were evaluated using BegoStones and compared for each laser mode: short (SP), long (LP), and Moses pulse (MP) for Ho:YAG, regular pulse (RP) and dual pulse (DP) for SPTFL. The Ho:YAG SP mode exhibited an asymmetrical pulse shape, with a steep leading slope and a much more gradual trailing slope, without any flat section. Pulses generated by the SPTFL were significantly longer and therefore had lower peak power than those generated by the Ho:YAG laser at equivalent energy settings. Retropulsion for the holmium:YAG LP and MP modes was similar and lower than that for the SP mode, but higher than for the SPTFL (all P ≤ 0.02), with an average stone displacement approximately four times and two times lower for SPTFL as compared to the Ho:YAG laser. Comparison of ablation volumes indicated that the SPTFL induced significantly higher (twofold) ablation than the Ho:YAG laser. The magnitude and initial velocity of stone retropulsion decreased with longer pulse duration and lower pulse peak power, without sacrificing ablation efficiency. These observations are manifest when comparing the Ho:YAG laser with the SPTFL. The novel SPTFL provides greater versatility and control of pulse variables than the Ho:YAG laser. Further clinical investigation of practical benefits achievable with pulse-shaping SPTFL modes is warranted.

Identifiants

pubmed: 32277557
doi: 10.1111/bju.15079
doi:

Substances chimiques

Thulium 8RKC5ATI4P
Holmium W1XX32SQN1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-167

Informations de copyright

© 2020 The Authors BJU International © 2020 BJU International Published by John Wiley & Sons Ltd.

Références

Türk C, Neisius A, Petrik Aet al. EAU guidelines on urolithiasis, 2018
Pierre S, Preminger GM. Holmium laser for stone management. World J Urol 2007; 25: 235-9
Lee H, Ryan RT, Teichman JMH et al. Stone retropulsion during holmium:YAG lithotripsy. J Urol 2003; 169: 881-5
Fried NM. Recent advances in infrared laser lithotripsy [Invited]. Biomed Opt Express 2018; 9: 4552-68
Andreeva V, Vinarov A, Yaroslavsky I et al. Preclinical comparison of superpulse thulium fiber laser and a holmium:YAG laser for lithotripsy. World J Urol 2020; 38: 497-503
Zheng B, Janmohamed Z, MacKenzie CL. Reaction times and the decision-making process in endoscopic surgery. Surg Endosc 2003; 17: 1475-80
Traxer O, Keller EX. Thulium fiber laser: the new player for kidney stone treatment? A comparison with Holmium:YAG laser. World J Urol 2019. [Epub ahead of print]. https://doi.org/10.1007/s00345-019-02654-5
Li R, Ruckle D, Keheila M et al. High-frequency dusting versus conventional holmium laser lithotripsy for intrarenal and ureteral calculi. J Endourol 2017; 31: 272-7
Kronenberg P, Traxer O. In vitro fragmentation efficiency of holmium: yttrium-aluminum-garnet (YAG) laser lithotripsy-a comprehensive study encompassing different frequencies, pulse energies, total power levels and laser fibre diameters. BJU Int 2014; 114: 261-7
Fried NM, Irby PB. Advances in laser technology and fibre-optic delivery systems in lithotripsy. Nat Rev Urol 2018; 15: 563-73
Wieliczka DM, Weng S, Querry MR. Wedge shaped cell for highly absorbent liquids: infrared optical constants of water. Appl Opt 1989; 28: 1714-9
Blackmon RL, Irby PB, Fried NM. Comparison of holmium:YAG and thulium fiber laser lithotripsy: ablation thresholds, ablation rates, and retropulsion effects. J Biomed Opt 2011; 16: 71403
Zhong P, Tong HL, Cocks FH, Pearle MS, Preminger GM. Transient cavitation and acoustic emission produced by different laser lithotripters. J Endourol 1998; 12: 371-8
Kronenberg P, Traxer O. Update on lasers in urology 2014: current assessment on holmium:yttrium-aluminum-garnet (Ho:YAG) laser lithotripter settings and laser fibers. World J Urol 2015; 33: 463-9
Bell JR, Penniston KL, Nakada SY. In vitro comparison of stone fragmentation when using various settings with modern variable pulse holmium lasers. J Endourol 2017; 31: 1067-72
Wollin DA, Ackerman A, Yang C et al. Variable pulse duration from a new Holmium:YAG Laser: the effect on stone comminution, fiber tip degradation, and retropulsion in a dusting model. Urology 2017; 47-51
Bell JR, Penniston KL, Nakada SY. In vitro comparison of holmium lasers: evidence for shorter fragmentation time and decreased retropulsion using a modern variable-pulse laser. Urology 2017; 107: 37-42
Elhilali MM, Badaan S, Ibrahim A, Andonian S. Use of the moses technology to improve holmium laser lithotripsy outcomes: a preclinical study. J Endourol 2017; 31: 598-604
Ventimiglia E, Traxer O. What is moses effect: a historical perspective. J Endourol 2019; 33: 353-7
Trost D. Laser pulse format for penetrating an absorbing fluid. United States Pat, 1994
Winship B, Wollin D, Carlos E et al. Dusting efficiency of the moses holmium laser: an automated in vitro assessment. J Endourol 2018; 32: 1131-5
Ibrahim A, Badaan S, Elhilali MM, Andonian S. Moses technology in a stone simulator. Can Urol Assoc J 2018; 12: 127-30

Auteurs

Eugenio Ventimiglia (E)

GRC n°20, Groupe de Recherche Clinique sur la Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, Paris, France.
Service d'Urologie, AP-HP, Hôpital Tenon, Sorbonne Université, Paris, France.

Steeve Doizi (S)

GRC n°20, Groupe de Recherche Clinique sur la Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, Paris, France.
Service d'Urologie, AP-HP, Hôpital Tenon, Sorbonne Université, Paris, France.

Anastasiya Kovalenko (A)

Moscow Engineering Physics Institute, Moscow, Russia.

Viktoria Andreeva (V)

Moscow Engineering Physics Institute, Moscow, Russia.

Olivier Traxer (O)

GRC n°20, Groupe de Recherche Clinique sur la Lithiase Urinaire, Hôpital Tenon, Sorbonne Université, Paris, France.
Service d'Urologie, AP-HP, Hôpital Tenon, Sorbonne Université, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH